in vitro might be a pathological phenomenon resulting from energy deprivation when glucose 93 is the sole energy source available in the ACSF. 94
In the present study, we examined whether an enriched ES pool affects inhibitory 95 synaptic transmission in the in vitro spinal cord preparation isolated from newborn rats. We 96 focused mainly on BHB, lactate and pyruvate which are considered as the major ES used by 97 
Data analysis 168
The number and the areas of spontaneous bursts were counted by using a software voltage 169 discriminator and a peak detector (pClamp9 software). DR recordings were rectified and 170 potential is referred to as E GABA/Gly . They were recorded after blocking excitatory amino acid 190 transmission using NMDA and non-NMDA receptor antagonists (AP5, 50 µM and CNQX, 10 191 µM, respectively). Changing the membrane potential by means of depolarizing or 192 hyperpolarizing current steps altered the amplitude of the IPSPs (Fig 1A) . Initially, E GABA/Gly 193 was measured in the presence of standard glucose-based ACSF. The latter was then 194 supplemented with either DL-BHB (4mM; n=17) or lactate (5mM; n=12) and E GABA/Gly was 195 determined at least 40 minutes after adding the ES to the saline solution. E GABA/Gly and V rest of 196 lumbar MNs were not affected significantly by supplementation of the standard ACSF with 197 DL-BHB or lactate ( Fig. 1A-C (Fig. 1H; p>0 .05, one-way ANOVA, Tukey post-test). E GABA/Gly was below V rest (-229 3.58±1.63 mV, n=6) at 5mM pyruvate whereas it was above V rest in control and under 150 230 µM pyruvate (Fig 1I; may be large enough to reach firing threshold and evoke action potentials that are conducted 243 antidromically (Fig. 3A) . Bursts of antidromic action potentials can be evoked in DR by 244 stimulation of neighbouring DR (Fig. 3B1-B2 these ES to the glucose-containing ACSF did not alter DRRs (Fig 3C1-C2 ; p>0.05, Wilcoxon 251 test, n=4 for both ES). Bumetanide which specifically blocks NKCC1 at low concentrations 252 (<100µM; Payne et al., 2003) significantly reduced the DRR in the presence of DL-BHB (Fig.  253 3D1; p<0.05, Paired t-test, n=4) or lactate (Fig. 3D2, p<0 .001, Paired t-test, n=4) thereby 254 confirming the excitatory actions of GABA. 255
256
Spontaneous activity recorded from lumbar DRs consists of bursts of action potentials 257 separated by silent periods (Fig. 4A, rectified Fig. 4B2; p>0 .05, one way ANOVA, Tukey post-test). As shown in Fig. 4B2, C) , 262 bumetanide (20 µM) significantly reduced the occurrence of spontaneous discharges both in 263 control ACSF (not shown, p<0.01, Wilcoxon test, n=8; see also Bos et al., 2011) and in the 264 presence of DL-BHB (Fig. 4B2 top; C, p<0 .05, one way ANOVA, Tukey post-test, n=4) or 265 lactate (Fig. 4B2 bottom, p<0 .001, one way ANOVA, Tukey post-test, n=4). Surprisingly, 266 when we monitored spontaneous activities with high non-physiological concentrations of 267 pyruvate (5mM, in addition to DL-BHB, 4mM; lactate, 5 mM) there was a significant 268 decrease in burst frequency ( It may be argued that E GABA/Gly was close to V rest at the studied postnatal ages and hence it 291
was more difficult to demonstrate a hyperpolarizing effect of adding ES to the ACSF. It 292 should be mentioned that DL-BHB was shown by Zilberter and colleagues to hyperpolarize 293 E GABA by as much as ~20 mV, even when E GABA was quite hyperpolarized (~-70 mV) in 294 control conditions (see Fig. 1d 
